Bioventus Inc - Ordinary Shares - Class A

NASDAQ:BVS  
13.91
-0.39 (-2.73%)
Earnings Announcements

Misonix Q4 Loss Per Share $0.26

Published: 09/02/2021 20:13 GMT
Bioventus Inc - Ordinary Shares - Class A (BVS) - Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results.
Q4 Revenue $19.7 Million Versus Refinitiv Ibes Estimate of $19 Million.
Q4 Loss per Share $0.26.
Revenue is expected to be $104.02 Million
Adjusted EPS is expected to be $0.17

Next Quarter Revenue Guidance is expected to be $116.43 Million
Next Quarter EPS Guidance is expected to be $0.29

More details on our Analysts Page.